SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-274707
Filing Date
2010-12-06
Accepted
2010-12-06 17:14:29
Documents
6
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 675584
2 CONSENT OF L.E.K. CONSULTING LLC dex23.htm EX-23 2502
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9864
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 10065
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4326
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4310
  Complete submission text file 0001193125-10-274707.txt   708176
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 101234856
SIC: 2834 Pharmaceutical Preparations